Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Astrana Health Inc. Market Cap
Based on ratings from 11 stock analysts, the Astrana Health Inc. stock price is expected to increase by 70.03% in 12 months. This is calculated by using the average 12-month stock price forecast for Astrana Health Inc.. The lowest target is $55 and the highest is $86. Please note analyst price targets are not guaranteed and could be missed completely.
Astrana Health Inc. has a total of 11 Wall St Analyst ratings. There are 10 buy ratings, 1 ratings, and 0 sell ratings. Since most analysts have a buy consensus rating, the expectation is that Astrana Health Inc. will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of ASTH.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Michael Ha Baird | Outperform | $86 | Maintains | Nov 13, 2024 |
| Ryan Langston TD Cowen | Buy | $66 | Initiates | Oct 14, 2024 |
| Matthew Gillmor Keybanc | Sector Weight | Initiates | Oct 11, 2024 | |
| David Larsen BTIG | Buy | $70 | Maintains | Oct 3, 2024 |
| Michael Ha Baird | Outperform | $67 | Maintains | Aug 15, 2024 |
| Jailendra Singh Truist Securities | Buy | $59 | Maintains | Aug 9, 2024 |
| Craig Jones Stifel | Buy | $60 | Maintains | Aug 1, 2024 |
| Jailendra Singh Truist Securities | Buy | $50 | Upgrade | Jul 11, 2024 |
| Craig Jones Stifel | Buy | $48 | Maintains | Jun 27, 2024 |
| Michael Ha Baird | Outperform | $54 | Initiates | May 30, 2024 |
| Craig Jones Stifel | Buy | $45 | Maintains | May 8, 2024 |
| Jailendra Singh Truist Securities | Hold | $44 | Maintains | Mar 1, 2024 |
Jefferies | Buy | Initiates | Feb 26, 2024 | |
B of A Securities | Buy | Upgrade | Feb 22, 2024 | |
Stifel | Buy | Initiates | Jan 24, 2024 | |
Truist Securities | Hold | Initiates | Dec 22, 2023 | |
BTIG | Buy | Initiates | Oct 17, 2023 | |
B of A Securities | Neutral | Initiates | Apr 12, 2023 | |
Lake Street | Buy | Maintains | Feb 27, 2023 | |
Lake Street | Buy | Initiates | Dec 19, 2022 |
When did it IPO
2007
Staff Count
1,800
Country
United States
Sector/Industry
Healthcare/Medical Care Facilities
CEO
Mr. Brandon K. Sim M.S.
Market Cap
$1.95B
In 2023, ASTH generated $1.39B in revenue, which was a increase of 21.19% from the previous year. This can be seen as a signal that ASTH's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Thu, 05 Dec 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Investors in the Medical - Outpatient and Home Healthcare sector are comparing Addus HomeCare (ADUS) and Astrana Health, Inc. (ASTH) for potential value opportunities.
Why It Matters - The comparison between Addus HomeCare and Astrana Health highlights potential investment opportunities in the outpatient and home healthcare sector, influencing stock selection and portfolio strategy.
Thu, 21 Nov 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Astrana Health, Inc. announced that eight of its affiliates received Elite status in the 2024 Standards of Excellence™ survey by America's Physician Groups, highlighting their commitment to quality care.
Why It Matters - Recognition of Astrana Health's affiliates as Elite status enhances its reputation, potentially attracting more providers and patients, which can drive revenue growth and increase shareholder value.
Sat, 09 Nov 2024
Sentiment - NEUTRAL
Source - Seeking Alpha
Summary - Astrana Health, Inc. (NASDAQ:ASTH) will hold its Q3 2024 earnings conference call on November 7, 2024, at 5:30 PM ET, featuring key executives and analysts from various firms.
Why It Matters - Astrana Health's Q3 earnings call provides critical insights into its financial performance and strategic direction, influencing stock valuation and investor sentiment.
Thu, 07 Nov 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - The company will hold a conference call on November 7, 2024, at 2:30 p.m. PT/5:30 p.m. ET for investors.
Why It Matters - The conference call may provide insights into the company's performance, future strategies, or financial updates, influencing stock price and investor sentiment.
Fri, 08 Nov 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Astrana Health, Inc. (NASDAQ: ASTH) announced a definitive agreement to acquire Prospect Health, including its healthcare service plan and medical groups across several states.
Why It Matters - Astrana Health's acquisition of Prospect Health expands its service offerings and geographic reach, potentially increasing revenue and market share, which could positively impact stock performance.
Thu, 07 Nov 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Astrana Health, Inc. (ASTH) reported quarterly earnings of $0.33 per share, matching estimates but down from $0.47 per share year-over-year.
Why It Matters - ASTH's earnings match estimates but show a decline from the previous year, signaling potential challenges in growth and profitability, which can impact investor sentiment and stock performance.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
